BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26124091)

  • 1. Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.
    Kim CH; Han BS; Moon J; Kim DJ; Shin J; Rajan S; Nguyen QT; Sohn M; Kim WG; Han M; Jeong I; Kim KS; Lee EH; Tu Y; Naffin-Olivos JL; Park CH; Ringe D; Yoon HS; Petsko GA; Kim KS
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8756-61. PubMed ID: 26124091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.
    Kambey PA; Chengcheng M; Xiaoxiao G; Abdulrahman AA; Kanwore K; Nadeem I; Jiao W; Gao D
    Metab Brain Dis; 2021 Apr; 36(4):609-625. PubMed ID: 33507465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
    Smith GA; Rocha EM; Rooney T; Barneoud P; McLean JR; Beagan J; Osborn T; Coimbra M; Luo Y; Hallett PJ; Isacson O
    PLoS One; 2015; 10(3):e0121072. PubMed ID: 25815475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models.
    Kim W; Tripathi M; Kim C; Vardhineni S; Cha Y; Kandi SK; Feitosa M; Kholiya R; Sah E; Thakur A; Kim Y; Ko S; Bhatia K; Manohar S; Kong YB; Sindhu G; Kim YS; Cohen B; Rawat DS; Kim KS
    Nat Commun; 2023 Jul; 14(1):4283. PubMed ID: 37463889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daphnane Diterpenes from Daphne genkwa Activate Nurr1 and Have a Neuroprotective Effect in an Animal Model of Parkinson's Disease.
    Han BS; Kim KS; Kim YJ; Jung HY; Kang YM; Lee KS; Sohn MJ; Kim CH; Kim KS; Kim WG
    J Nat Prod; 2016 Jun; 79(6):1604-9. PubMed ID: 27228307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.
    Spathis AD; Asvos X; Ziavra D; Karampelas T; Topouzis S; Cournia Z; Qing X; Alexakos P; Smits LM; Dalla C; Rideout HJ; Schwamborn JC; Tamvakopoulos C; Fokas D; Vassilatis DK
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3999-4004. PubMed ID: 28348207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1.
    Munoz-Tello P; Lin H; Khan P; de Vera IMS; Kamenecka TM; Kojetin DJ
    J Med Chem; 2020 Dec; 63(24):15639-15654. PubMed ID: 33289551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin A2 Interacts with Nurr1 and Ameliorates Behavioral Deficits in Parkinson's Disease Fly Model.
    Rajan S; Toh HT; Ye H; Wang Z; Basil AH; Parnaik T; Yoo JY; Lim KL; Yoon HS
    Neuromolecular Med; 2022 Dec; 24(4):469-478. PubMed ID: 35482177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
    Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.
    Hammond SL; Safe S; Tjalkens RB
    Neurosci Lett; 2015 Oct; 607():83-89. PubMed ID: 26383113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
    Hedya SA; Safar MM; Bahgat AK
    Mol Neurobiol; 2018 Sep; 55(9):7579-7587. PubMed ID: 29429051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function.
    Rajan S; Jang Y; Kim CH; Kim W; Toh HT; Jeon J; Song B; Serra A; Lescar J; Yoo JY; Beldar S; Ye H; Kang C; Liu XW; Feitosa M; Kim Y; Hwang D; Goh G; Lim KL; Park HM; Lee CH; Oh SF; Petsko GA; Yoon HS; Kim KS
    Nat Chem Biol; 2020 Aug; 16(8):876-886. PubMed ID: 32451509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
    Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
    Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
    Lei Z; Jiang Y; Li T; Zhu J; Zeng S
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment.
    Jodeiri Farshbaf M; Forouzanfar M; Ghaedi K; Kiani-Esfahani A; Peymani M; Shoaraye Nejati A; Izadi T; Karbalaie K; Noorbakhshnia M; Rahgozar S; Baharvand H; Nasr-Esfahani MH
    Mol Cell Biochem; 2016 Sep; 420(1-2):29-42. PubMed ID: 27435855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene.
    Li QJ; Tang YM; Liu J; Zhou DY; Li XP; Xiao SH; Jian DX; Xing YG
    Synapse; 2007 Dec; 61(12):971-7. PubMed ID: 17879263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models.
    Liu W; Gao Y; Chang N
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1312-1319. PubMed ID: 27940361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms.
    Willems S; Ohrndorf J; Kilu W; Heering J; Merk D
    J Med Chem; 2021 Mar; 64(5):2659-2668. PubMed ID: 33629841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurr1-Based Therapies for Parkinson's Disease.
    Dong J; Li S; Mo JL; Cai HB; Le WD
    CNS Neurosci Ther; 2016 May; 22(5):351-9. PubMed ID: 27012974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model.
    Moon M; Jung ES; Jeon SG; Cha MY; Jang Y; Kim W; Lopes C; Mook-Jung I; Kim KS
    Aging Cell; 2019 Feb; 18(1):e12866. PubMed ID: 30515963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.